{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:43:24Z","timestamp":1757630604618,"version":"3.44.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004881","name":"Instituto Mexicano del Seguro Social","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina de Familia. SEMERGEN"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.semerg.2025.102461","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T05:24:38Z","timestamp":1742966678000},"page":"102461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nirmatrelvir\/ritonavir prescription and the risk of hospitalization and death in COVID-19 outpatients"],"prefix":"10.1016","volume":"51","author":[{"given":"H.R.","family":"Vargas-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Tom\u00e1s-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Guzm\u00e1n-Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Alarc\u00f3n-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Krug-Llamas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Arizmendi-Uribe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Dom\u00ednguez-Z\u00e1rate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Fern\u00e1ndez-G\u00e1rate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.J.","family":"Ascencio-Montiel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2025.102461_bib0105","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1080\/14787210.2023.2241638","article-title":"Nirmatrelvir and ritonavir combination: an antiviral therapy for COVID-19","volume":"21","author":"Navitha Reddy","year":"2023","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.semerg.2025.102461_bib0110","doi-asserted-by":"crossref","first-page":"115667","DOI":"10.1016\/j.ejmech.2023.115667","article-title":"Exploring diverse reactive warheads for the design of SARS-CoV-2 main protease inhibitors","volume":"259","author":"Tan","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.semerg.2025.102461_bib0115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.37201\/req\/002.2022","article-title":"Nirmatrelvir plus ritonavir (Paxlovid) a potent SARS-CoV-2 3CLpro protease inhibitor combination","volume":"35","author":"Reina","year":"2022","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.semerg.2025.102461_bib0120","doi-asserted-by":"crossref","first-page":"m3379","DOI":"10.1136\/bmj.m3379","article-title":"A living WHO guideline on drugs for covid-19","volume":"370","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"year":"2022","series-title":"Therapeutics and COVID-19: living guideline [Internet] (WHO Guidelines Approved by the Guidelines Review Committee)","key":"10.1016\/j.semerg.2025.102461_bib0125"},{"key":"10.1016\/j.semerg.2025.102461_bib0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12941-023-00623-w","article-title":"Pan-American guidelines for the treatment of SARS-CoV-2\/COVID-19: a joint evidence-based guideline of the Brazilian Society of Infectious Diseases (SBI) and the Pan-American Association of Infectious Diseases (API)","volume":"22","author":"Barbosa","year":"2023","journal-title":"Ann Clin Microbiol Antimicrob"},{"year":"2022","series-title":"Lineamiento operativo en el uso de emergencia de Paxlovid\u00ae (nirmatrelvir\/ritonavir) en grupos de riesgo para COVID-19, en M\u00e9xico","key":"10.1016\/j.semerg.2025.102461_bib0135"},{"year":"2023","series-title":"Informe al Ejecutivo Federal y al Congreso de la Uni\u00f3n sobre la Situaci\u00f3n Financiera y los Riesgos del Instituto Mexicano del Seguro Social 2022-2023","key":"10.1016\/j.semerg.2025.102461_bib0140"},{"key":"10.1016\/j.semerg.2025.102461_bib0145","article-title":"Nirmatrelvir combined with ritonavir for preventing and treating COVID-19","volume":"9","author":"Reis","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semerg.2025.102461_bib0150","doi-asserted-by":"crossref","first-page":"e2473","DOI":"10.1002\/rmv.2473","article-title":"Efficacy and safety of Paxlovid (nirmatrelvir\/ritonavir) in the treatment of COVID-19: an updated meta-analysis and trial sequential analysis","volume":"33","author":"Tian","year":"2023","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.semerg.2025.102461_bib0155","doi-asserted-by":"crossref","first-page":"e28441","DOI":"10.1002\/jmv.28441","article-title":"Efficacy and safety of nirmatrelvir\/ritonavir (Paxlovid) for COVID-19: a rapid review and meta-analysis","volume":"95","author":"Amani","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.semerg.2025.102461_bib0160","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ptj\/79.2.186","article-title":"Statistical inference by confidence intervals: issues of interpretation and utilization","volume":"79","author":"Sim","year":"1999","journal-title":"Phys Ther"},{"key":"10.1016\/j.semerg.2025.102461_bib0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/M22-2141","article-title":"Nirmatrelvir plus ritonavir for early COVID-19 in a large U.S. Health System: a population-based cohort study","volume":"176","author":"Dryden-Peterson","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semerg.2025.102461_bib0170","doi-asserted-by":"crossref","first-page":"E220","DOI":"10.1503\/cmaj.221608","article-title":"Population-based evaluation of the effectiveness of nirmatrelvir\u2013ritonavir for reducing hospital admissions and mortality from COVID-19","volume":"195","author":"Schwartz","year":"2023","journal-title":"CMAJ"},{"key":"10.1016\/j.semerg.2025.102461_bib0175","first-page":"100602","article-title":"Association of molnupiravir and nirmatrelvir\u2013ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among high-risk patients with mild to moderate COVID-19","volume":"30","author":"Wai","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.semerg.2025.102461_bib0180","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jinf.2023.02.012","article-title":"Real-world effectiveness of molnupiravir, nirmatrelvir\u2013ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: a retrospective cohort study","volume":"86","author":"Evans","year":"2023","journal-title":"J Infect"},{"key":"10.1016\/j.semerg.2025.102461_bib0185","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1473-3099(23)00118-4","article-title":"Effectiveness of nirmatrelvir\u2013ritonavir in preventing hospital admissions and deaths in people with COVID-19: a cohort study in a large US health-care system","volume":"23","author":"Lewnard","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.semerg.2025.102461_bib0190","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.medin.2021.08.002","article-title":"Impact of vaccination on admissions to an intensive care unit for COVID-19 in a third-level hospital","volume":"46","author":"Gonz\u00e1lez-Castro","year":"2022","journal-title":"Med Intensiva (Engl Ed)"},{"key":"10.1016\/j.semerg.2025.102461_bib0195","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/cid\/ciae105","article-title":"Combined protection of vaccination and nirmatrelvir\u2013ritonavir against hospitalization in adults with COVID-19","volume":"79","author":"Shah","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.semerg.2025.102461_bib0200","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"}],"container-title":["Medicina de Familia. SEMERGEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359325000140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359325000140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T19:16:34Z","timestamp":1757531794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359325000140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1138359325000140"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2025.102461","relation":{},"ISSN":["1138-3593"],"issn-type":[{"type":"print","value":"1138-3593"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nirmatrelvir\/ritonavir prescription and the risk of hospitalization and death in COVID-19 outpatients","name":"articletitle","label":"Article Title"},{"value":"Medicina de Familia. SEMERGEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semerg.2025.102461","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de M\u00e9dicos de Atenci\u00f3n Primaria (SEMERGEN). Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102461"}}